Showing results (271-280 of 451) with videos related to
Sort By:
Pageof 46
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.Stroke|September 10, 1998
High prevalence of antiphosphatidylinositol antibodies in young patients with cerebral ischemia of undetermined causeV Toschi, A Motta, C Castelli, et al.The Cancer Journal From Scientific American|January 1, 1997
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan AJ N Cormier, M L Salgaller, T Prevette, et al.The American Journal of Pathology|December 1, 1992
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanomaN Jonjic, I Martìn-Padura, T Pollicino, et al.Annals of Surgical Oncology|January 1, 1995
Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanomaM Vaglini, F Belli, M Santinami, et al.La Ricerca in Clinica E in Laboratorio|January 1, 1986
Adoptive immunotherapy of cancer with immune and activated lymphocytes: experimental and clinical studiesG Parmiani, M L Sensi, A Balsari, et al.Cancer Research|September 29, 1998
Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibodyC Melani, M Figini, D Nicosia, et al.The Journal of Clinical Investigation|September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanomaP Nisticò, R Mortarini, L B De Monte, et al.International Journal of Cancer|May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.Pageof 46